Reinier de Graaf Groep   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Delft Netherlands (1996)

Organization Overview

First Clinical Trial
2006
NCT00332735
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Reinier de Graaf Groep